Page last updated: 2024-10-28

hydroxyurea and Demyelinating Diseases

hydroxyurea has been researched along with Demyelinating Diseases in 1 studies

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Adult macaque Schwann cells were infected using adeno-associated virus type-2-derived vectors expressing the green fluorescent protein reporter gene under the control of the cytomegalovirus, the hybrid cytomegalovirus-betaactin, the myelin basic protein or the tetracycline-inducible promoters."3.73Efficiency of adeno-associated virus type-2 vectors in non-human primate Schwann cells. ( Attali, B; Bachelin, C; Baron-Van Evercooren, A; Chtarto, A; Girard, C; Lachapelle, F; Salvetti, A; Tenenbaum, L, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Girard, C1
Tenenbaum, L1
Chtarto, A1
Attali, B1
Salvetti, A1
Bachelin, C1
Baron-Van Evercooren, A1
Lachapelle, F1

Other Studies

1 other study available for hydroxyurea and Demyelinating Diseases

ArticleYear
Efficiency of adeno-associated virus type-2 vectors in non-human primate Schwann cells.
    Neuroreport, 2005, Nov-07, Volume: 16, Issue:16

    Topics: Analysis of Variance; Animals; Cell Count; Cell Proliferation; Cell Transplantation; Cells, Cultured

2005